Shuhei Nishiguchi
Overview
Explore the profile of Shuhei Nishiguchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
320
Citations
5002
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Possible Use of Body Surface Area Value for Estimating Skeletal Muscle Mass in Chronic Liver Disease
Yoh K, Nishimura T, Ikeda N, Takashima T, Aizawa N, Yuri Y, et al.
Diagnostics (Basel)
. 2025 Feb;
15(3).
PMID: 39941193
Sarcopenia is an important clinical feature of patients with chronic liver disease (CLD). However, special devices are required to determine skeletal muscle mass. We evaluated the usefulness of body surface...
2.
Nakamura T, Masuda A, Kako M, Enomoto H, Kaibori M, Fujita Y, et al.
Regen Ther
. 2024 May;
27:455-463.
PMID: 38737403
Introduction: In this multicenter clinical study, we aimed to investigate the efficacy and safety of the transhepatic arterial administration of granulocyte-colony stimulating factor (G-CSF)-mobilized autologous peripheral blood (PB)-CD34 cells compared...
3.
Korenaga M, Murata K, Izumi N, Tamaki N, Yokosuka O, Takehara T, et al.
Glob Health Med
. 2022 Sep;
4(4):216-224.
PMID: 36119787
It is well-known that sustained virological response (SVR) by interferon (IFN)-based therapy against hepatitis C virus (HCV) infection reduced the incidence of hepatocellular carcinoma (HCC). However, whether IFN-free direct-acting antivirals...
4.
Inoue-Yuri M, Enomoto H, Wakabayashi I, Yuri Y, Aizawa N, Ikeda N, et al.
In Vivo
. 2022 Apr;
36(3):1360-1366.
PMID: 35478164
Background/aim: A new scoring system [albumin-bilirubin-platelet (ALBI-PLT) score] was reported for identifying cirrhotic patients without high-risk varices (HRV), and patients with ALBI grade 1 (≤-2.60) and a platelet count over...
5.
Serum miR-192-5p levels predict the efficacy of pegylated interferon therapy for chronic hepatitis B
Nagura Y, Matsuura K, Iio E, Fujita K, Inoue T, Matsumoto A, et al.
PLoS One
. 2022 Feb;
17(2):e0263844.
PMID: 35157730
We examined the association between serum miRNA (-192-5p, -122-3p, -320a and -6126-5p) levels and the efficacy of pegylated interferon (Peg-IFN) monotherapy for chronic hepatitis B (CHB) patients. We enrolled 61...
6.
Nishikawa H, Asai A, Fukunishi S, Takeuchi T, Goto M, Ogura T, et al.
In Vivo
. 2021 Oct;
35(6):3001-3009.
PMID: 34697131
The elderly people are characterized by multiple comorbidities, dementia, and are at risk of developing sarcopenia and frailty. Sarcopenia is defined by loss of muscle mass and muscle strength or...
7.
Nishikawa H, Asai A, Fukunishi S, Nishiguchi S, Higuchi K
Nutrients
. 2021 Oct;
13(10).
PMID: 34684520
Skeletal muscle is a major organ of insulin-induced glucose metabolism. In addition, loss of muscle mass is closely linked to insulin resistance (IR) and metabolic syndrome (Met-S). Skeletal muscle loss...
8.
Nishikawa H, Fukunishi S, Asai A, Yokohama K, Ohama H, Nishiguchi S, et al.
Mol Med Rep
. 2021 Oct;
24(6).
PMID: 34651658
Skeletal muscle is the largest and most energy‑consuming organ in the human body, which plays an important role in energy metabolism and glucose uptake. There is a notable decrease in...
9.
Nishikawa H, Nakamura S, Miyazaki T, Kakimoto K, Fukunishi S, Asai A, et al.
J Clin Med
. 2021 Sep;
10(18).
PMID: 34575326
Malnutrition is a major contributor to muscle loss and muscle dysfunction, known as sarcopenia. Malnutrition is common in patients with inflammatory bowel disease (IBD). IBD includes ulcerative colitis (UC) and...
10.
Minamisakamoto T, Nishiguchi S, Hashimoto K, Ogawara K, Maruyama M, Higaki K
Eur J Pharm Biopharm
. 2021 Aug;
169:20-28.
PMID: 34461216
To improve the anti-tumor effect of polyethylene glycol-modified liposome containing doxorubicin (DOX-PEG liposome), the effect of sequential administration of PEG-Span 80 niosome was investigated for Colon-26 cancer cells (C26)-bearing mice....